WhiteOak Capital Pharma and Healthcare Fund-Dir (G) logo

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

NAV ₹14.67 as on 17 Nov 2025

RiskVery High

Fund Size₹480.08Cr

NAV₹14.67 as on 17 Nov 2025
RiskVery High
Fund Size₹480.08Cr

Download 3-in-1 Torus App
Trade at flat ₹11/order & Zero AMC
demat with one powerful SuperApp.

Investment Details
Top Rated Funds

Lock-in

No Lock-in

Min One Time Amount

₹500

Min Withdrawal Amount

₹-

Min SIP Amount

₹100

Min Additional Amount

₹500

Exit Load

In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

Basic Details

Age

1 years 9 months (Since Feb 06, 2024)

Return since Launch

24.01%

Expense ratio

0.65%

Type

OPEN

AUM (Fund Size)

₹480.08

Risk Grade

Very High

Benchmark

BSE Healthcare TRI

Calculate Your Returns
Select Duration
Choose Amount
Returns
Total investment of ₹2,40,000
Would have become ₹61,949 (+209.74%)
Fund Manager

Name:

Ramesh Mantri

Experience:

Over 20 years' experience in financial market: 1. WhiteOak Capital Asset Management Limited (December 21, 2021 - till now) 2. White Oak Capital Management (June 2017 to December 21, 2021) 3. Ashoka Capital Advisers (February 2013- May 2017) 4. Smith Management-Mumbai Office (September 2005 - January 2013)

Scheme Holding Summary
RiskometerLevel of risk in the scheme
Moderate
High
Low
Very
High

Your investment will be at Very High Risk

Fund house & investment objective
Rank (total assets)#27 in India
Total AUM₹24,943.48Cr
Date of Incorporation21 Apr 2017
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 06 Feb 2024. The fund currently has an Asset Under Management(AUM) of ₹24,943.48 Cr and the Latest NAV as of 17 Nov 2025 is ₹14.67.
The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹500. Exit load of In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment..
...Read more
Returns and Rankings

Category: Equity Sectoral / Thematic

1Y3Y5YAll
Fund returns13.42%--24.01%
Category average8.02%6.14%3.98%-
Rank within category4711995-

FAQ’s

What kind of returns does WhiteOak Capital Pharma and Healthcare Fund Direct Growth provide?

WhiteOak Capital Pharma and Healthcare Fund Direct Growth has given a return of NA% in the past 3 years.

What is the expense ratio charged by WhiteOak Capital Pharma and Healthcare Fund Direct Growth?

The Expense Ratio charged by WhiteOak Capital Pharma and Healthcare Fund Direct Growth is 0.65%.

What is the AUM size of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?

The AUM size of WhiteOak Capital Pharma and Healthcare Fund Direct Growth is ₹480.08Cr.

What is the minimum SIP amount that you can invest in WhiteOak Capital Pharma and Healthcare Fund Direct Growth?

₹100 is the minimum SIP amount that you can invest in WhiteOak Capital Pharma and Healthcare Fund Direct Growth .

What are the top stock holdings of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?

The top stock holdings of WhiteOak Capital Pharma and Healthcare Fund Direct Growth include , Sun Pharmaceutical Industries Ltd , Divis Laboratories Ltd , J B Chemicals & Pharmaceuticals Ltd and Laurus Labs Ltd.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.